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Ultraviolet (UV) radiation (290–400 nm) 
in sunlight can affect people’s health in both 
detrimental and beneficial ways. Short-term 
detrimental health effects include sunburn 
and immune suppression, and long-term det-
rimental health effects include cataracts, pho-
toaging, and DNA damage with mutations 
that can lead to non  melanoma and melanoma 
skin cancers. Beneficial health effects of UV 
radiation include medical detection and treat-
ments of diseases such as cancers; possible 
reduction in the mortality from some can-
cers, including colon cancer (Garland et al. 
1989), breast and prostate cancer (Freedman 
et al. 2002), and melanoma (Berwick et al. 
2005); and vitamin D3 production (Holick 
et al. 1980).
Children may need more vitamin D3 than 
amounts recently recommended (600 IU/day) 
by the Institute of Medicine (2011) to main-
tain healthy muscles (Pfeifer et al. 2002), 
bones (Holick 2007), and general health 
(Heaney and Holick 2011; Holick 2011). 
For example, the risk of type 1 diabetes may 
be significantly reduced in children if they 
take 2,000 IU/day of vitamin D supplements 
early in life (Ponsonby et al. 2009; Zipitis and 
Akobeng 2008). Conversely, there is some 
evidence that infants who develop rickets, 
a consequence of vitamin D deficiency, are 
at increased risk of type 1 diabetes mellitus 
(Hyppönen et al. 2001). Thus, correct lev-
els of vitamin D may prevent or reduce the 
occurrence of type 1 diabetes mellitus (Harris 
2005).
For most children, the major source of 
vitamin D3 comes from exposing their skin 
to sunlight (Glerup et al. 2000). In animals, 
yeast, fungi, and plants, sunlight forms either 
vitamin D3 or D2, both of which may be 
equally effective in maintaining human serum 
levels of 25-hydroxy  vitamin D [25(OH)
D; D represents both D2 and D3; Holick 
et al. 2008]. Vitamin D3 production occurs 
in human skin when ultraviolet B (UVB; 
290–315 nm) photons convert 7-dehydro-
cholesterol, or provitamin D3, made by kera-
tinocytes to previtamin D3 (MacLaughlin 
et al. 1982), which thermally isomerizes to 
vitamin D3 (Holick et al. 1995b). Vitamin D3 
that forms in the skin and vitamin D2 or 
D3 from dietary sources are carried into the 
bloodstream by vitamin D–binding protein, 
an alpha1 globulin. The liver enzyme vitamin 
D-25-hydroxylase hydroxylates it to 25(OH)
D, and then the kidney enzyme 25(OH)
D-1-α-hydroxylase further hydroxylates it to 
the hormonally active form, 1,25-dihydroxy-
vitamin D [1,25(OH)2D]. In addition to 
liver and kidney cells, most cells in the body 
can convert either vitamin D or 25(OH)D to 
1,25(OH)2D, including colon, breast, lung, 
and prostate cells, keratinocytes, and mela-
noma cells (Reichrath et al. 2007; Zehnder 
et al. 2001).
Most people in the United States do not 
get sufficient vitamin D from dietary sources 
[fortified foods and drinks (milk and orange 
juice) and supplements] (Moore et al. 2004), 
so sunlight-derived vitamin D is their primary 
source. However, because the incidence of skin 
cancers is increasing at an alarming rate, pub-
lic health organizations have warned people, 
especially children, to stay out of the sunlight 
whenever possible and to wear protective 
clothing, sunglasses, and sunscreens with sun 
protection factor (SPF) 15 or higher while out-
doors from 1000 hours to 1600 hours. (e.g., 
Goldman 2002; Skin Cancer Foundation 
2011; U.S. Environmental Protection Agency 
2011). Although sunscreens with SPF ≥ 15 
almost completely inhibit vitamin D3 pro-
duction (Holick et al. 1995a; Matsuoka et al. 
1988), the American Academy of Dermatology 
has concluded that people will still make 
“ample” vitamin D3 (≥ 1,000 IU/day) because 
they get plenty of “casual,” or everyday, out-
door UV exposure (Lim et al. 2005). However, 
an evaluation of serum 25(OH)D revealed 
that about half of all American children have 
either deficient or insufficient levels (Gordon 
et al. 2004, 2008; Looker et al. 2002, 2008; 
Mansbach et al. 2009).
To clarify whether “casual” sunlight expo-
sures make ample vitamin D3, we calculated 
the amounts produced from everyday outdoor 
UV dose estimates (Godar 2001) according 
to sex, age, Fitzpatrick skin type (Fitzpatrick 
1988), clothing (Matsuoka et al. 1992), and 
season for children in the northern and south-
ern United States.
Materials and Methods
We extracted and calculated erythemally 
weighted UV doses (Godar et al. 2001) from 
a 2-year survey of 9,386 Americans residing in 
the contiguous United States, including about 
2,000 children (≤ 19 years) (Godar 2001). We 
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Ba c k g r o u n d: Sunlight contains ultraviolet B (UVB) radiation (290–315 nm) that affects human 
health in both detrimental (skin cancers) and beneficial (vitamin D3) ways. Serum 25-hydroxy-
vitamin D concentrations from young Americans (≤ 19 years) show that many have deficient 
(< 50 nmol/L, 20 ng/mL) or insufficient (< 75 nmol/L, 30 ng/mL) vitamin D levels, indicating that 
they are not getting enough sun exposure. Those findings are in conflict with some calculated, pub-
lished values that suggest people make “ample” vitamin D3 (~ 1,000 IU/day) from their “casual,” or 
everyday, outdoor exposures even if they diligently use sunscreens with sun protection factor (SPF) 15. 
oB j e c t i v e: We estimated how much vitamin D3 young Americans (n = ~ 2,000) produce from 
their everyday outdoor ultraviolet doses in the North (45°N) and South (35°N) each season of the 
year with and without vacationing. 
Me t h o d s : For these vitamin D3 calculations, we used geometric conversion factors that change pla-
nar to whole-body doses, which previous calculations did not incorporate. 
re s u l t s: Our estimates suggest that American children may not be getting adequate outdoor UVB 
exposures to satisfy their vitamin D3 needs all year, except some Caucasians during the summer if 
they do not diligently wear sunscreens except during beach vacations. 
co n c l u s i o n: These estimates suggest that most American children may not be going outside 
enough to meet their minimal (~ 600 IU/day) or optimal (≥ 1,200 IU/day) vitamin D requirements.
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converted the average daily standard erythemal 
dose (SED; a UV dose weighted by the erythe-
mal action spectrum, so that it is independent 
of the spectral output of the source and the 
individual’s skin type; 1 SED = 100 J/m2) 
for each season to standard vitamin D3 doses 
(SVDs) relative to the horizontal plane using 
action spectrum conversion factors (ASCFs; 
Pope et al. 2008), and then converted those 
planar dose estimates to human body doses 
using geometric conversion factors (GCFs; 
Pope and Godar 2010). An action spectrum 
shows the relative effectiveness of each wave-
length (nanometers) toward some end point 
that can be used to weight spectral outputs 
of different sources like the sun or a tanning 
bed in order to estimate amounts produced—
for example, erythemal response (sunburn) or 
vitamin D3 production.
The ASCFs account for the differences 
between wavelength contributions estimated 
by the erythemal action spectrum and the 
previtamin D action spectrum toward previ-
tamin D3 production. To derive the SVD for 
a given season and latitude, we multiplied the 
SED per day by the appropriate ASCF:
  SVD = SED/day × ASCF.   [1]
ASCFs for the northern (45°N) and south-
ern (35°N) United States are 1.034 and 1.104 
for summer, 0.879 and 1.029 for fall, 0.565 
and 0.842 for winter, and 0.9 and 1.049 for 
spring, respectively (Pope et al. 2008).
SVDs, which represent horizontal plane 
or planar doses, are converted to whole-body 
doses using GCFs based on a full-cylinder 
model representing the human body (Pope 
and Godar 2010). GCFs for the northern 
United States (45°N) are 0.434 during the 
summer and spring and 0.508 during the 
winter and fall; GCFs for the southern United 
States (35°N) are 0.417 during the summer 
and spring and 0.484 during the winter and 
fall. The average vitamin D3 dose (VDD) per 
day is derived by multiplying the SVD by the 
appropriate GCF:
  VDD = SVD × GCF.   [2]
To estimate the amount of vitamin D3 
a person makes from outdoor UV exposures 
when engaged in different activities, we first 
determined how much vitamin D3 a person 
would make from an erythemally weighted 
UV dose with uniform geometry, such as 
the UV dose from a tanning bed. For exam-
ple, a female with Fitzpatrick skin type II 
(Caucasian; Fitzpatrick 1988) with a whole-
body exposure to one minimum erythemal 
dose (MED), or the amount of UV needed 
to barely turn skin pink after 24 hr, in a tan-
ning bed with a weighted spectral distribution 
similar to the midday summer sun at approxi-
mately 35°N produces the equivalent of an 
oral dose of approximately 15,500 IU vita-
min D2 or D3 (Holick et al. 2008). Because 
melanin impedes the penetration of UVB 
and reduces vitamin D3 production (Clemens 
et al. 1982; Matsuoka et al. 1991), the UV 
dose required to achieve an MED and make 
the same amount of vitamin D varies by skin 
type. For Fitzpatrick skin type II (Fitzpatrick 
1988), 1 MED is defined as 250–350 J/m2, 
and so we refer to skin type II as 300 J/m2 or 
3 SED. For a whole-body exposure, a person 
with skin type II with an MED of 320 J/m2 
will make approximately 15,500 IU/MED 
or approximately 4,900 IU/SED. Similarly, 
1 MED is 300–500 J/m2 or 4 SED (average) 
for skin type III (olive skin tone, Hispanic 
or Asian), 450–600 J/m2 or 5.25 SED for 
skin type IV (brown skin tone, e.g., Indian), 
600–900 J/m2 or 7.5 SED for skin type V 
(light-skinned African American), and for skin 
type VI (dark-skinned African American), 
600–2,000 J/m2 or approximately 13 SED. 
Consequently, for a given UVB dose, 
Caucasians with skin type II make at least 
two to three times more vitamin D3 than do 
African Americans with skin type V (Dong 
et al. 2010; Matsuoka et al. 1991) and 10–20 
times more than do African Americans with 
skin type VI (Clemens et al. 1982). The ratio 
of vitamin D production for someone with 
skin type II compared with other skin types, 
referred to as the skin type factor (STF), is 
used to adjust predictions for each skin type: 
3.2/3 for skin type II, 3.2/4 for type III, 
3.2/5.25 for skin type IV, and 3.2/7.5 for skin 
type V. We did not calculate vitamin D values 
for skin type VI because they are below those 
of skin type V, which has very low values.
The amount of vitamin D3 people make 
from outdoor UV exposures also depends on 
how much skin they expose to the sun, or the 
percent body exposure (PBE). To get the best 
estimates of how much body area people expose 
or PBE during each season of the year, we used 
estimates for burn areas (Lund and Browder 
1944). For example, we assumed that young 
adults would expose the face (4.5–7.8%), the 
front half of the neck (1%), and the front and 
back of both hands (5%) during all seasons of 
the year (PBE ~ 10.5–13.8%; Table 1) and 
would also expose the lower arms (6%) and 
lower legs (10–13%) during the spring and fall 
(PBE ~ 30%) and half of the upper arms (4%; 
short-sleeved/T-shirts) and half of the upper 
legs (7–9%; shorts/skirts) during the summer 
(PBE ~ 41–44%).
Because vitamin D3 production decreases 
with age (MacLaughlin and Holick 1985), 
we included an age factor (AF) in the calcula-
tions. Young adults (< 22 years of age), who 
have the highest ability to make vitamin D3, 
are assigned an AF = 1, and adults (≥ 22 years 
of age) are assigned fractions according to 
their age range (Godar et al. 2011). Therefore, 
the final equation for calculating the amount 
of vitamin D3 produced from an average 
everyday UV exposure during each season of 
the year is
.
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For example, during the summer, a 
4-year-old African-American girl with skin 
type V living near Atlanta, Georgia (~ 34°N), 
and wearing a T-shirt and short shorts 
(thus exposing ~ 40.8% of her body area; 
see Table 1) would get, on average, about 
1 SED/day (Godar 2001) (~ 2 hr outdoors, 
scattered throughout the day) and would make 
about 397 IU of vitamin D3 per day [vitamin 
D3 (IU/day) = ([1.01 SED × 1.104] × 0.417) 
× (4,900 IU) × (3.2/7.5) × 0.408 × 1.0].
To account for sunscreen use, divide the 
estimate from Equation 3 by the SPF fac-
tor (Matsuoka et al. 1988). However, this 
assumes that sunscreens are used correctly, 
that is, that they are applied generously to the 
entire body before going outdoors and are 
reapplied every 2 hr.
To account for additional sun exposure 
during vacations, we recalculated estimates 
assuming that 2–3 weeks each summer were 
spent vacationing at approximately 40°N, as 
estimated by Godar et al. (2001), with the 
use of SPF 4 sunscreen or the equivalent 
only during beach vacations. In addition, we 
averaged exposures for four different types of 
vacations—beach, sightseeing, country, and 
home—and assumed that people would wear 
the least amount of clothing during a summer 
vacation (PBE ~ 50–90%), depending on the 
type of vacation.
Table 1. Estimates of PBE for each season, by age 
(based on data from Lund and Browder 1944).
Age (years)
Exposure (%) 0–5 10 15 ≥ 22
Half of head (face) 7.8 5.5 4.5 3.5
Half of neck (front) 1 1 1 1
Hands (front and back) 5 5 5 5
Lower arms 6 6 6 6
Lower legs 10 12 13 14
Half of upper arms 4 4 4 4
Half of upper legs 7 8.5 9 9.5
Totala
Winter 13.8 11.5 10.5 9.5
Spring/fall 30 29.5 29.5 15.5
Summer  40.8 42 43.5 33.5
For summer only
Upper arms 8 8 8 8
Upper legs 14 17 18 19
Trunk 26 26 26 26
Feet 7 7 7 7
Bathing suit/diaper 85.6 88.5 89.5 90.5
aThe data for percent body part for the age range of 0–5 
years was weighted by age (Lund and Browder 1944). Outdoor UV doses of young Americans and vitamin D3 production
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Results
Table 1 shows estimates for PBE by differ-
ent age groups during each season of the 
year, based on the data of Lund and Browder 
(1944). During the winter body exposure is 
highest in young children (≤ 5 years), and 
during the rest of the year body exposure is 
highest in teenagers (13–19 years). Adults 
(≥ 22 years) have the lowest PBE during all 
seasons. Note here that levels of vitamin D3 
can increase during the summer by ≥ 30% 
(~ 500 IU/day) depending on clothing choice 
(data not shown).
Figure 1 shows estimates of the average 
amount of vitamin D3 made by children 
with Fitzpatrick skin type II according to sea-
son, age group, sex, diligent use of SPF 15 
sunscreen, and residence in the northern or 
southern United States. According to our 
estimates, the minimum recommended daily 
dose of vitamin D (600 IU/day; Institute of 
Medicine 2011) is achieved by skin type II 
children in the northern United States only 
during the summer and only if they do not 
wear sunscreen with SPF ≥ 15 (Figure 1A). 
However, results suggest that most children 
with skin type II in the southern United 
States can get the recommended daily dose 
during the spring and summer if they do not 
wear sunscreen with SPF ≥ 15 (Figure 1B). 
Optimal vitamin D3 production (≥ 1,200 
IU/day) is achieved primarily by a subset of 
children in the southern United States during 
the summer (Dong et al. 2010).
Figure 2 shows the average amount of 
vitamin D3 produced from everyday outdoor 
exposure according to skin type (II–V), sea-
son, and residence in the northern or south-
ern United States for all children ≤ 19 years 
combined (without using sunscreen). Our 
estimates suggest that in the northern United 
States (Figure 2A), the minimum recom-
mended daily dose of vitamin D3 (600 
IU/day) is made by skin type II, III, and 
IV children only during the summer, and 
the optimal dose of ≥ 1,200 IU/day is not 
made during any season, regardless of skin 
type, except by a small subset of skin type 
II children during the summer (Figure 1A). 
In the southern United States (Figure 2B), 
we estimate that the minimum amount 
(600 IU/day) is achieved during the summer 
by children with skin types II, III, and IV and 
during the spring by children with skin type II 
only, whereas the optimum amount (≥ 1,200 
IU/day) is achieved only by children with 
skin type II during the summer (Figure 2B). 
These findings suggest that everyday outdoor 
exposure for children with skin type III and 
skin type IV rarely provides their minimum 
vitamin D3 needs (~ 600 IU/day), and chil-
dren with skin type V may never meet their 
minimum daily vitamin D needs. 
Taking a 2- or 3-week summer vacation at 
40°N during the summer increases the average 
estimated vitamin D3 production for children 
of all skin types but still may be insufficient 
to meet minimum or optimum requirements 
in children with skin type V because these are 
optimistic estimates (minimum clothing and 
maximum time outdoors and no sunscreens) 
[Figure 3; UV doses estimated by Godar et al. 
(2001)].
Discussion
Although our estimates assumed “opti-
mistic” clothing scenarios for making vita-
min D3, they raise the question as to whether 
American children are going outdoors enough 
to meet their minimum daily vitamin D 
requirements (600 IU/day; for blood levels 
of 20 ng/mL or 50 nmol/L) recommended by 
the Institute of Medicine (2011). The amount 
of time varies by season (Godar 2001). Based 
Figure 1. Average estimated vitamin D3 production by American children with skin type II according to age (years), sex, season, sunscreen use, and residence in 
the northern (45°N; A) or southern (35°N; B) United States.
1,600
1,400
1,200
1,000
800
600
400
200
0
1,600
1,400
1,200
1,000
800
600
400
200
0
V
i
t
a
m
i
n
 
D
3
 
(
I
U
)
/
d
a
y
V
i
t
a
m
i
n
 
D
3
 
(
I
U
)
/
d
a
y
Summer
No SPF
 SPF 15  SPF 15
No SPF
Fall Winter Spring Summer Fall Winter Spring
0–5 years, female
0–5 years, male
6–12 years, female
6–12 years, male
13–19 years, female
13–19 years, male
Figure 2. Average estimated vitamin D3 produced in children (≤ 19 years of age) from everyday outdoor UV exposures in the northern (45°N; A) or southern 
(35°N; B) United States, according to Fitzpatrick skin type and season (without use of sunscreen with SPF ≥ 15).
1,400
1,200
1,000
800
600
400
200
0
1,400
1,200
1,000
800
600
400
200
0
V
i
t
a
m
i
n
 
D
3
 
(
I
U
)
/
d
a
y
V
i
t
a
m
i
n
 
D
3
 
(
I
U
)
/
d
a
y
Summer Fall Winter Spring Summer Fall Winter Spring
Skin type II
Skin type III
Skin type IV
Skin type VGodar et al.
142  v o l u m e  120 | n u m b e r 1 | January 2012  •  Environmental Health Perspectives
on the results of this analysis, it appears that 
most active Caucasian children of skin type II 
can make optimal amounts of vitamin D3 
(≥ 1,200 IU/day for blood levels of 30 ng/mL 
or 75 nmol/L) during the summer, but only 
if they do not use sunscreens diligently except 
during beach vacations. However, children 
with darker skin may never achieve optimal 
production, whereas those with skin types 
III and IV may meet only minimum require-
ments during the summer, and children with 
very dark skin (type V) may meet their opti-
mum requirements during the summer only if 
they take a 3-week beach vacation at latitudes 
lower than 40°N (approximate middle of the 
United States).
If children really need to achieve optimal 
blood levels of 30 ng/mL (~ 75 nmol/L), then 
they need at least twice the current recom-
mendation, or about 1,200 IU/day of vita-
min D. However, two recent studies, which 
examined > 25 children in each different skin 
type and sun exposure category, concluded 
that children need ≥ 2,000 IU/day from oral 
supplements (Maalouf et al. 2008), equivalent 
UV exposure, or a combination (Hall et al. 
2010) to maintain blood levels of 25(OH)D 
> 75 nmol/L. If children really need ≥ 2,000 
IU/day, then almost no one in the United 
States can make the needed amount of vita-
min D3 from everyday sun exposure all year.
Overall, males go outside somewhat more 
than females, and children in the youngest age 
group (≤ 5 years) go outside somewhat more 
than do those in the other age groups (Godar 
2001), so they make a little more vitamin D3, 
in agreement with the findings of three recent 
large U.S. studies (Ginde et al. 2009; Looker 
et al. 2008; Mansbach et al. 2009). Children 
spend approximately 1.6 ± 0.1 hr/day (week-
days and weekends averaged) outdoors dur-
ing the summer (Godar 2001), giving them 
about two-thirds of an MED for a skin type II 
body exposure (Pope and Godar 2010). If the 
children are Caucasian with skin type II and 
wear minimal clothing (e.g., wear a diaper, 
shorts, or a bathing suit, or females wear tank 
or halter tops and short shorts, or males do 
not wear a shirt and wear short shorts), then 
they can make at least 30% more than the 
estimated vitamin D3 (~ 500 IU/day; data not 
shown). In contrast, if people wear sunscreen 
with SPF ≥ 15, they will make virtually no 
vitamin D3 (Holick et al. 1995a; Matsuoka 
et al. 1988).
Our estimates are consistent with reports 
of vitamin D deficiency (< 50 nmol/L, 
< 20 ng/mL) and insufficiency (< 75 nmol/L, 
< 30 ng/mL) among children and adolescents 
in the United States. For example, the Third 
National Health and Nutrition Examination 
Survey (NHANES III 1988–1994) study 
showed that 13% of male and 29% of female 
adolescents (12–19 years) had deficient levels 
and that 25% of male and 47% of female 
adolescents had insufficient levels of 25(OH)
D during the winter (Looker et al 2002). 
During the summer, 8% of males and 13% of 
females had deficient levels and 21% of males 
and 28% of females had insufficient levels of 
25(OH)D. In addition, the percentage of chil-
dren with deficient levels during the winter 
increased with increasing skin color: skin types 
I/II, 8% male and 15% female; skin types 
III/IV, 18% male and 41% female; skin types 
V/VI, 53% male and 70% female. NHANES 
2000–2004 data indicated that approximately 
20% more Americans were vitamin D defi-
cient compared with the previous decade, 
partly because of increased sun protection 
(Ginde et al. 2009; Looker et al. 2008; 
Mansbach et al. 2009). A study in Augusta, 
Georgia (33°N), examined 559 adolescents 
and found that during the winter, 3.9% of 
male and 2.6% of female adolescents with 
skin type II had deficient levels of 25(OH)
D, and 46.9% of male and 73.8% of female 
adolescents had insufficient levels (Dong et al. 
2010). The same study also showed that dur-
ing the winter, 84% of African Americans 
with skin types V and VI had deficient levels 
of 25(OH)D and 98% had insufficient levels, 
whereas during the summer 56% had defi-
cient and 88% had insufficient levels. A study 
in Pittsburgh, Pennsylvania (40°N), of 41 
preadolescent African Americans (6–10 years 
of age) found that 49% had deficient 25(OH)
D levels (Rajakumar et al. 2005). The recent 
resurgence of rickets in breast-fed African-
American infants in several southern states 
suggests that vitamin D deficiency is on the 
rise in the United States (Kreiter et al. 2000). 
Similar insufficient and deficient levels of 
25(OH)D are found in young adults in the 
southern hemisphere at comparable latitudes 
(35–46°S; Rockell et al. 2005), where they get 
UV doses similar to those in the United States 
(Godar 2005). Insufficient sun exposure in 
adults is also a concern, particularly because 
the ability to make vitamin D decreases 
with age; seniors > 70 years of age can make 
only 25–50% of what a child can make 
(MacLaughlin and Holick 1985). Deficient 
and insufficient vitamin D levels from insuf-
ficient sun exposure are a worldwide problem 
with serious health consequences (Holick and 
Chen 2008).
Conversely, serious health consequences 
can also arise from too much sun expo-
sure. Too much UV radiation can lead to 
the formation of three types of skin cancers: 
squamous cell carcinoma, basal cell carci-
noma, and melanoma. Paradoxically, regu-
lar, moderate sun exposure may reduce the 
incidence of fatal melanoma (Godar et al. 
2009). Melanoma cells have been shown 
to convert vitamin D3 to 1,25(OH)2D 
in vitro (Reichrath et al. 2007), and it has 
been reported that 1,25(OH)2D can reduce 
tumor growth and decrease the number and 
size of skin tumors and melanoma xenografts 
in animal models (Eisman et al. 1987) and 
inhibit in vivo pulmonary metastasis (Yudoh 
et al. 1999) and angiogenesis (Mantell et al. 
2000). Further, continual rather than inter-
mittent outdoor UV exposure has been asso-
ciated with a reduced incidence of melanoma 
(Gandini et al. 2005; Kennedy et al. 2003) 
relative to the cumulative annual UV dose 
(Godar 2005), and sun exposure has been 
associated with increased survival in mela-
noma patients (Berwick et al. 2005). Thus, it 
has been suggested that promoting protection 
from all midday UV exposures and advising 
the diligent use of sunscreens with SPF ≥ 15 
may paradoxically be promoting the incidence 
of melanoma (Godar et al. 2009; Gorham 
et al. 2007).
In conclusion, our estimates suggest that 
many children may not get enough sun expo-
sure to meet their minimum daily vitamin D 
requirements. However, additional research 
is needed to confirm our estimates and to 
improve our understanding of the net benefits 
and risks of sun exposure to children’s health.
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